| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |